Giving Patients a Screening Choice Matters

When patients  were offered a choice of colorectal cancer screening with either FOBT or colonoscopy, they were significantly more likely to complete that screening than when their doctors recommended only FOBT or only colonoscopy. Nearly 1000 racially and ethnically diverse patients in urban primary care practices were randomly assigned to get colorectal cancer screening via: Fecal occult…  Read More

Do You Need that Test? Wise Choices from Gastroenterologists

How soon should average risk people get another colorectal cancer screening after they have a normal colonoscopy? No sooner than 10 years, the American Gastroenterological Association recommends as part of the Choosing Wisely campaign. The AGA’s list of Five Things Physicians and Patients Should Question includes: Use the lowest possible effective dose of acid reducing medicines…  Read More

Choosing Wisely: What CancerTests and Treatments Do You Really Need?

Oncologists have joined eight other physician specialty organizations in the Choosing Wisely® campaign with a list of the Top Five Cancer-Related Tests, Procedures, and Treatments That Many Patients Do Not Need. Choosing Wisely asked each of the specialist groups to come up with a list of five things doctors and patients should question in order to…  Read More

Disappointing Results for Perifosine

Perifosine was no better than a placebo in improving survival time for people with late-stage colorectal cancer according to a news release from Keryx Biopharmaceuticals. Despite success in a smaller Phase II clinical trial, the X-PECT Phase III trial failed to meet its primary objective — longer survival time. X-PECT randomized 468 patients to receive either:…  Read More

Fighting Crisis in Cancer Funding Named Number One Priority for AACR

The American Association for Cancer Research (AACR) says that declining budgets at the National Institutes of Health a crisis standing in the way of bringing cancer research to patient’s lives. For the past ten years, NIH budgets have been essentially flat.  Factoring in rising research costs, flat funding means a loss of nearly $6 billion dollars…  Read More

Watch Fight Colorectal Cancer Ring the NASDAQ Bell

Fight Colorectal Cancer President Carlea Bauman was joined by staff, survivors, advocates and fighters to “get behind a cure” and ring the NASDAQ closing bell. [vimeo=http://vimeo.com/39477231] We ring the bell to bring attention that colorectal cancer is the number two cancer killer in America. We need awareness that colorectal cancer can be prevented, treated, and beaten.…  Read More